BOSTON — While many worried during the heat of the pandemic that college campuses would be COVID hot spots, a new study out of Boston University shows what strategies worked
A new Alzheimer's disease monoclonal antibody treatment that takes aim at a new target for the progressive disease has shown promising results, according to Boston researchers.
A new Alzheimer's disease monoclonal antibody treatment that takes aim at a new target for the progressive disease has shown promising results, according to Boston researchers.
A new Alzheimer's disease monoclonal antibody treatment that takes aim at a new target for the progressive disease has shown promising results, according to Boston researchers.
A new Alzheimer's disease monoclonal antibody treatment that takes aim at a new target for the progressive disease has shown promising results, according to Boston researchers.